Assessing uMotif’s smartphone based Parkinson’s wellbeing tracker
1 like634 views
The document evaluates a smartphone app designed for individuals with Parkinson's disease to aid in medication management and health behavior tracking. Users reported high engagement with the app, leading to improved medication adherence, better health behaviors, and enhanced well-being. The next steps include further development of the app, funded trials, and a randomized control trial to assess its efficacy across multiple NHS trusts.
Assessing uMotif’s smartphone based Parkinson’s wellbeing tracker
- 1. Assessing uMotif’s smartphone based Parkinson’s wellbeing tracker Dr. Caspar Addyman*,1 Bruce Hellman2 and Dr. Jon Stamford3 *Correspondence email c.addyman@bbk.ac.uk 3. Cure Parkinson’s Trust St Botolphs, Aldgate High Street London EC3N 1AB 1. Centre for Brain and Cognitive Development (CBCD), Birkbeck, University of London, Malet Street, London, WC1E 7HX, UK 2. uMotif Limited, UK www.uMotif.com contact@uMotif.comuMotif DigitalHealth Midlands and East Pre & post test questionnaires Cognitive Testing 1 2 3 4 5 START END AverageSelfRating Suppleness scores 1 2 3 4 5 START ENDAverageSelfRating Tremor scores 1 2 3 4 5 START END AverageSelfRating Dyskinesia scores 1 2 3 4 5 START END AverageSelfRating Bradykinesia scores Parkinson’s symptoms Limited App (N=14) Full App (N=15) † p<.1, * p<.05, ** p<.01,*** p<.005 Health Behaviours *** 1 2 3 4 5 START END Exercise 1 2 3 4 5 START END Water * 1 2 3 4 5 START END AverageSelfRating Medication Well Being Measures 1 2 3 4 5 START END Energy ** 1 2 3 4 5 START END Sleep † 1 2 3 4 5 START END AverageSelfRating Mood † Daily Self Report Data Background The current research evaluates a new smartphone app designed to help people with Parkinson’s Disease manage their medication & improve their health behaviours through self-tracking. The app also represents an interesting new research platform for in-situ testing of cognitive performance. Detailed daily tracking provides the potential to empower and motivate patients with long term conditions, encouraging them to engage positively with the management of their conditions while providing better data to healthcare professionals. Trial Summary • Users reported engagement with tracking and ease of use • App was used on average 38.5 out of 55 days (70%) • App provides rich new source of data on the daily effects of Parkinson’s Disease • Self-tracking leads to - Improved medication adherence – Improved health behaviours (water & exercise) – Improved well being (mood, sleep & energy) Next Steps • Successful second round NHS SBRI funding (June 2013 – June 2014) • Extensive further development of smartphone app and web portal • Randomised Control Trial (RCT) – 300 person, multi-centre trial across 6 NHS trusts in England and Scotland – 4 month trial period (Jan-May 2014) – Using Full app. vs. Treatment As Usual – Evaluation by Neurologists & PD nurses Design Web-based portal for Health Professionals Pre TrialPre Trial Daily Self Report Medicine Reminders Tapping Test Numerical Stroop Partial 41 people with Parkinson’s initially recruited Questionnaires PDQ-39, Parkinson’s Non-Motor Symptoms (NMS), Quality of Life Score (QOLS), Morisky Medicines Adherence 6-8 Weeks 6-8 Weeks PARTIAL APP N = 14 FULLAPP N = 15 Post Trial Post Trial FullFull Questionnaires N = 10 Questionnaires N = 6 Results